Kroner, Antje <br/><br/>
The co-inhibitory molecule PD-1 modulates disease severity in a model for an inherited, demyelinating neuropathy.  [electronic resource] 

 -  Neurobiology of disease  Jan 2009 
 - 96-103 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-953X 
<br/><br/><label>Standard No.: </label>10.1016/j.nbd.2008.09.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, Surface--metabolism<br/>Apoptosis Regulatory Proteins--metabolism<br/>CD8-Positive T-Lymphocytes--immunology<br/>Charcot-Marie-Tooth Disease<br/>Chimera<br/>Demyelinating Diseases--immunology<br/>Disease Models, Animal<br/>Flow Cytometry<br/>Gait Apraxia--physiopathology<br/>Interferon-gamma--metabolism<br/>Lymphocyte Activation<br/>Macrophages--immunology<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Transgenic<br/>Peripheral Nervous System Diseases--immunology<br/>Programmed Cell Death 1 Receptor<br/>Quadriceps Muscle--innervation<br/>Sciatic Nerve--physiopathology<br/>Spinal Nerve Roots--physiopathology<br/>Statistics, Nonparametric<br/>Touch--physiology